Recent studies proposed that deficiency or pharmacological blockade of C5aR1 significantly impeded tumorigenesis of CRC, and the over-expression of C5aR1 contributed to the poor prognosis of CRC patients (40, 41). The gene discussed is C5AR1; the disease is colorectal carcinoma.